£2.3M
The biomedical startup has closed a £2.3m Series A round backed by Mercia Asset Management, ACF Investors, Wren Capital and Wealth Club.
Adapttech
Adapttech develops wearable biomedical technologies to improve the quality of life for people with physical limitations.
£4.3MTotal raised
Adapttech is a biomedical enterprise that creates wearable technologies to assist individuals with physical limitations. Its flagship offering combines 3D scanning with dynamic pressure data to streamline prosthetic fitting.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Adapttech's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
FC
Frederico Carpinteiro
CEO
Frederico brings operating experience as founder and chief executive of Amparo and Adapttech. He also holds an academic role as an invited professor at Faculdade de Engenharia da Universidade do Porto.
LinkedInSM
Stuart Mead
Chairman
Stuart serves as chairman at Adapttech and Amparo, alongside non-executive chairman roles at HKR Insight Limited and 2PD Ltd. He previously held the position of CEO at Fuel3D.
LinkedInInvestors
- £2.3M
- £2.0M
Funding history
£2.0M
The biomedical startup has raised £2m from backers including Mercia and Bionova Capital.